The fast-paced future of cell and gene therapies

In this free report, the Medical, Consulting, Policy, Access, Value, and Evidence experts of Fishawack Health interview patients, researchers, and biopharmaceutical leaders to explore the complex landscape in the development of cell and gene therapies, and share commercial recommendations from our specialist teams.

Follow the link to learn about: 

  1. An interview with Professor Francesco Dazzi, Medical Lead Cell Therapy, BioPharmaceuticals R&D at AstraZeneca, on the company’s novel cell therapy pipeline for chronic diseases 

  2. Patient and market access insights on leveraging CRISPR technology for hematologic diseases 

  3. The evolving policy and regulatory landscape for cell and gene therapies 

  4. Trends shaping the future of personalized medicine 

  5. Steps for communicating the complex science to a variety of stakeholders 

FREE Whitepaper

The fast-paced future of cell and gene therapies

The data you submit here will be processed by us, and our partners within Fishawack Health, as outlined in our privacy policy, cookie policy, and terms and conditions.

Latest insights

Driving BioPharma Access in Europe: Insights for ...

PRMA Consulting becomes Avalere Health, creating the ...

World Orphan Drug Congress 2023: solutions for market ...